← Leaderboards
Wenyong Chen
Beckman Research Institute/City Of Hope
$3,166,948
Attributed
$3,166,948
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $463.8K · FY2011–23$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,166,948 · 5
By mechanism
R01$1,540,464 · 1
R21$876,855 · 2
UH3$599,629 · 1
UH2$150,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Guido Marcucci$19,718,636
- Steven Terry Rosen$39,410,931
- Bin Zhang$2,891,856
Others in their field
Top investigators on “Hematopoietic Stem Cells”
- Mary M Horowitz · Medical College Of Wisconsin$222,127,419
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$80,540,126
- David T Scadden · Massachusetts General Hospital$40,987,034
- David A Williams · Indiana Univ-Purdue Univ At Indianapolis$36,503,708
- Irving Lerner Weissman · Stanford University$36,281,548
- Bruce R. Blazar · University Of Minnesota$33,175,355
Research focus
Hematopoietic Stem CellsMalignant NeoplasmsInsightKnock-OutChronic Myeloid LeukemiaMouse ModelProteinsDeacetylaseAgingImatinibPathogenesisBcr-Abl Fusion ProteinsMolecularTransplantationDrug ResistanceLeukemia TreatmentInhibitor/AntagonistLeukemiaLongevityOncogenicBiological Adaptation To StressDisease ProgressionMalignant - DescriptorMaintenance
Grant awards (15)
Modeling and Targeting B/Myeloid Mixed Phenotype Acute Leukemia$210,906
R21 · FY2023 · CA · contact PI
Modeling and Targeting B/Myeloid Mixed Phenotype Acute Leukemia$252,046
R21 · FY2022 · CA · contact PI
A Novel E3 Ubiquitin Ligase for CML Stem Cells$188,138
R21 · FY2020 · CA · contact PI
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia$151,531
UH3 · FY2020 · CA · contact PI
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia$124,152
UH3 · FY2020 · CA · contact PI
A Novel E3 Ubiquitin Ligase for CML Stem Cells$225,765
R21 · FY2019 · CA · contact PI
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia$148,948
UH3 · FY2019 · CA · contact PI
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia$174,998
UH3 · FY2018 · CA · contact PI
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia$98,590
UH2 · FY2017 · CA · contact PI
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia$51,410
UH2 · FY2016 · CA · contact PI
Roles of SIRT1 in normal hematopoietic and leukemic stem cells$313,740
R01 · FY2015 · CA · contact PI
Roles of SIRT1 in normal hematopoietic and leukemic stem cells$304,328
R01 · FY2014 · CA · contact PI
Roles of SIRT1 in normal hematopoietic and leukemic stem cells$294,916
R01 · FY2013 · CA · contact PI
Roles of SIRT1 in normal hematopoietic and leukemic stem cells$313,740
R01 · FY2012 · CA · contact PI
Roles of SIRT1 in normal hematopoietic and leukemic stem cells$313,740
R01 · FY2011 · CA · contact PI